STADA

STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi

European Commission grants approval for Gotenfia, a golimumab biosimilar to Simponi that was developed by Bio-Thera and will be marketed by STADA Launch preparations are underway to bring the second approved golimumab biosimilar to patients across Europe in the coming weeks and months Bio-Thera is responsible for development, manufacture and supply; STADA for commercialization in...